NO993606L - Fluoreterblandinger og fremgangsmater for a forhindre degradering derav i naervaer av en Lewis-syre - Google Patents

Fluoreterblandinger og fremgangsmater for a forhindre degradering derav i naervaer av en Lewis-syre

Info

Publication number
NO993606L
NO993606L NO19993606A NO993606A NO993606L NO 993606 L NO993606 L NO 993606L NO 19993606 A NO19993606 A NO 19993606A NO 993606 A NO993606 A NO 993606A NO 993606 L NO993606 L NO 993606L
Authority
NO
Norway
Prior art keywords
degradation
preventing
methods
lewis acid
fluoride mixtures
Prior art date
Application number
NO19993606A
Other languages
English (en)
Norwegian (no)
Other versions
NO993606D0 (no
Inventor
Christopher Bieniarz
Steve H Chang
Keith R Cromack
Shuyen L Huang
Toshikazu Kawai
Manami Kobayashi
David Loffredo
Rajagopalan Raghavan
Earl R Speicher
Honorate A Stelmach
Original Assignee
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25148366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO993606(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Central Glass Co Ltd filed Critical Central Glass Co Ltd
Publication of NO993606D0 publication Critical patent/NO993606D0/no
Publication of NO993606L publication Critical patent/NO993606L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
NO19993606A 1997-01-27 1999-07-23 Fluoreterblandinger og fremgangsmater for a forhindre degradering derav i naervaer av en Lewis-syre NO993606L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/789,679 US5990176A (en) 1997-01-27 1997-01-27 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
PCT/US1998/001376 WO1998032430A1 (en) 1997-01-27 1998-01-23 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid

Publications (2)

Publication Number Publication Date
NO993606D0 NO993606D0 (no) 1999-07-23
NO993606L true NO993606L (no) 1999-09-24

Family

ID=25148366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993606A NO993606L (no) 1997-01-27 1999-07-23 Fluoreterblandinger og fremgangsmater for a forhindre degradering derav i naervaer av en Lewis-syre

Country Status (28)

Country Link
US (6) US5990176A (ja)
EP (2) EP1114641B1 (ja)
JP (5) JP3183520B2 (ja)
KR (1) KR100368672B1 (ja)
CN (3) CN1152674C (ja)
AR (2) AR011090A1 (ja)
AT (2) ATE201987T1 (ja)
AU (1) AU726733B2 (ja)
BG (2) BG109751A (ja)
BR (1) BR9806996A (ja)
CA (2) CA2278133C (ja)
CO (1) CO4920220A1 (ja)
CZ (1) CZ297092B6 (ja)
DE (2) DE69800928T2 (ja)
DK (2) DK0967975T3 (ja)
ES (2) ES2256104T3 (ja)
GR (1) GR3036190T3 (ja)
HK (1) HK1074434A1 (ja)
HU (1) HUP0002101A3 (ja)
IL (1) IL130150A (ja)
NO (1) NO993606L (ja)
NZ (1) NZ335994A (ja)
PL (1) PL334477A1 (ja)
PT (2) PT1114641E (ja)
SK (1) SK284243B6 (ja)
TR (1) TR199901579T2 (ja)
WO (1) WO1998032430A1 (ja)
ZA (1) ZA98418B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
US6162443A (en) 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
US20030200963A1 (en) * 1998-01-09 2003-10-30 Flament-Garcia Mary Jane Container for an inhalation anesthetic
US6074668A (en) * 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
AU759641B2 (en) * 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
EP1439677B9 (en) 1999-01-08 2007-11-07 Sony Deutschland GmbH Synchronisation symbol structure for an OFDM system
TW523409B (en) * 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
BR0303489A (pt) * 2003-09-10 2005-07-05 Cristalia Prod Quimicos Farm Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
DE602004007149T2 (de) * 2003-09-10 2008-02-28 Cristália Produtos Químicos Farmacêuticos Ltda. Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether-verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung
WO2006113636A2 (en) * 2005-04-18 2006-10-26 Minrad Inc. Preparation of sevoflurane with negligible water content
WO2009049460A1 (fr) * 2007-10-15 2009-04-23 Jiangsu Hengrui Medicine Co., Ltd. Nouveau matériau conditionné de sévoflurane
WO2009094459A1 (en) * 2008-01-22 2009-07-30 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
US20090275785A1 (en) 2008-05-01 2009-11-05 Barry Jones Distillation Method For The Purification Of Sevoflurane And The Maintenance Of Certain Equipment That May Be Used In The Distillation Process
US8563115B2 (en) * 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8092822B2 (en) * 2008-09-29 2012-01-10 Abbott Cardiovascular Systems Inc. Coatings including dexamethasone derivatives and analogs and olimus drugs
US8283643B2 (en) * 2008-11-24 2012-10-09 Cymer, Inc. Systems and methods for drive laser beam delivery in an EUV light source
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
US9278048B2 (en) * 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
US9102604B1 (en) 2010-02-15 2015-08-11 Baxter International Inc. Methods for cleaning distilling columns
CN105193774B (zh) * 2015-09-21 2018-01-16 山东新时代药业有限公司 一种七氟烷吸入剂
CN105106182B (zh) * 2015-09-21 2017-12-29 山东新时代药业有限公司 七氟烷吸入剂
BE1024432B1 (fr) 2016-11-02 2018-02-19 Central Glass Company, Limited Procédé pour le lavage de récipient de stockage de sévoflurane et procédé pour le stockage de sévoflurane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2992276A (en) * 1959-05-20 1961-07-11 Du Pont Process for preparing polyfluoro alkyl compounds
US3527813A (en) * 1966-10-03 1970-09-08 Air Reduction 1,1,2 - trifluoro - 2 - chloroethyl difluoromethyl ether and its method of preparation
US3689571A (en) * 1970-07-31 1972-09-05 Baxter Laboratories Inc Fluorinated ether
GB1499818A (en) * 1974-12-06 1978-02-01 Ici Ltd Anaesthetic composition
US4250334A (en) * 1979-12-26 1981-02-10 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
US4469898A (en) * 1979-12-26 1984-09-04 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
JP2786108B2 (ja) * 1994-03-31 1998-08-13 セントラル硝子株式会社 フルオロメチル−１，１，１，３，３，３−ヘキサフルオロイソプロピルエーテルの精製方法
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5990176A (en) 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

Also Published As

Publication number Publication date
AU726733B2 (en) 2000-11-16
DK1114641T3 (da) 2006-05-15
IL130150A (en) 2004-09-27
EP0967975B1 (en) 2001-06-13
JP2005279283A (ja) 2005-10-13
US20020016373A1 (en) 2002-02-07
JP2006143742A (ja) 2006-06-08
AR011090A1 (es) 2000-08-02
US6288127B1 (en) 2001-09-11
HUP0002101A2 (hu) 2001-05-28
JP2000510159A (ja) 2000-08-08
CO4920220A1 (es) 2000-05-29
CN1152674C (zh) 2004-06-09
AR057610A2 (es) 2007-12-05
CZ297092B6 (cs) 2006-09-13
BG109751A (bg) 2008-06-30
JP2001187729A (ja) 2001-07-10
US6677492B2 (en) 2004-01-13
EP1114641B1 (en) 2006-03-22
PL334477A1 (en) 2000-02-28
CA2278133A1 (en) 1998-07-30
CA2278133C (en) 2001-06-26
DE69800928T2 (de) 2001-11-22
CA2626424A1 (en) 1998-07-30
JP3183520B2 (ja) 2001-07-09
WO1998032430A1 (en) 1998-07-30
ATE320798T1 (de) 2006-04-15
ES2256104T3 (es) 2006-07-16
IL130150A0 (en) 2001-03-19
CN1899271A (zh) 2007-01-24
TR199901579T2 (xx) 1999-12-21
SK86199A3 (en) 2000-06-12
US5990176A (en) 1999-11-23
DK0967975T3 (da) 2001-09-17
HK1074434A1 (en) 2005-11-11
EP1114641A3 (en) 2003-05-28
US20040048932A1 (en) 2004-03-11
KR20000070482A (ko) 2000-11-25
EP0967975A1 (en) 2000-01-05
US6444859B2 (en) 2002-09-03
US20060148906A1 (en) 2006-07-06
US20030130359A1 (en) 2003-07-10
KR100368672B1 (ko) 2003-01-24
CN1560003A (zh) 2005-01-05
GR3036190T3 (en) 2001-10-31
BG65414B1 (bg) 2008-07-31
NZ335994A (en) 2000-08-25
SK284243B6 (sk) 2004-12-01
PT967975E (pt) 2001-11-30
BR9806996A (pt) 2000-03-14
ATE201987T1 (de) 2001-06-15
CN1321958C (zh) 2007-06-20
DE69833884T2 (de) 2006-08-24
EP1114641A2 (en) 2001-07-11
JP2006137769A (ja) 2006-06-01
NO993606D0 (no) 1999-07-23
DE69800928D1 (de) 2001-07-19
BG103656A (en) 2000-04-28
DE69833884D1 (de) 2006-05-11
ZA98418B (en) 1999-04-20
JP3664648B2 (ja) 2005-06-29
AU5930098A (en) 1998-08-18
CZ256199A3 (cs) 1999-11-17
HUP0002101A3 (en) 2002-03-28
PT1114641E (pt) 2006-05-31
CN1244797A (zh) 2000-02-16
ES2170474T3 (es) 2002-08-01

Similar Documents

Publication Publication Date Title
NO993606L (no) Fluoreterblandinger og fremgangsmater for a forhindre degradering derav i naervaer av en Lewis-syre
FI962055A (fi) Pariston jatkolaite ja siihen liittyvä menetelmä
NO940277D0 (no) Triglycerider og blandinger av slike
FI942744A (fi) Metalloseeneja ja siihen liittyviä menetelmiä
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
NO302965B1 (no) Stillas
ITMI940144A0 (it) Soluzioni e loro preparazione
NO995247D0 (no) Benyttelse av utstyr i et brönnsystem
FI950908A0 (fi) Antitussiivi
BR9407089A (pt) Moega e método
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
NO972103L (no) Eleutherobin og analoger av denne
NO983556D0 (no) Formulering og anvendelse
NO930418D0 (no) Innstikkbar helletut
EE9400194A (et) Seinakonstruktsioon ja sellel baseeruv ehitusmeetod
FI974619A (fi) Menetelmä kattoristikkoelementtien valmistamiseksi ja menetelmässä käytettävä laite
KR950006606U (ko) 텐트
KR950011644U (ko) 발판 겸용 빨래판
DE4481315D2 (de) Transportgerüst
DK123593D0 (da) Straekfast og dimensionsstabil gulvbelaegning
KR940027426U (ko) 조립식 단소
FI933996A0 (fi) Prefabricerad foerbindningsplatta
ATA232793A (de) Lagereinrichtung
ITMI931648A1 (it) Azaciclo e azabiciclo ammidi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application